Organon is a pharmaceutical company that specializes in the development, production, and distribution of medical products. Organon was founded in the Netherlands in 1923 and has since become one of the leading manufacturers of pharmaceutical products.
Organon is known for its innovative and high-quality products in various medical fields. The company actively works in areas such as gynecology, endocrinology, psychiatry, hematology, as well as immunology and allergology.
One of Organon's well-known products is "Organon Sustanon 250," a medication that contains a blend of four different forms of testosterone and is used for testosterone replacement therapy in men with insufficient or absent natural testosterone.
Organon invests heavily in research and development of new drugs, as well as clinical trials, to provide patients with more effective and safe medications.
In 2007, Organon was acquired by Schering-Plough Corporation, and later, Schering-Plough merged with Merck & Co., Inc. As a result of the merger, Organon became a division of Merck & Co., Inc.
Organon continues its operations as a pharmaceutical company, aiming to improve the health and quality of life for patients worldwide.